Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
RAPAMUNE® (sirolimus) - Important Safety Information from Wyeth Pharmaceuticals Limited as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
04/02/2010
Problem Or Issue:
Important Safety Information communication from Wyeth on immunoassay product changes and their impact on the therapeutic drug monitoring of RAPAMUNE
®
(sirolimus).
Important Safety Information - RAPAMUNE® (sirolimus)
« Back
Date Printed: 05/05/2024